Skip to content

Clinical trials

Phase 3 Thromboembolism trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thromboembolism Phase: Phase 3 Country / region: Germany Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20051
20063
20071
20091
20121
20131
20143
20161
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer5
Boehringer Ingelheim5
AstraZeneca1
Daiichi Sankyo1
Janssen Research & Development, LLC1
Novartis1
Population Health Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thromboembolism15
Stroke4
Venous Thromboembolism4
Venous Thrombosis3
Atrial Fibrillation2
Ischemic Attack, Transient2
Pulmonary Embolism2
Thrombosis2
Cerebrovascular Disorders1
Communicable Diseases1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.